Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

计划入组 6 人 · 首次发布于 2025 年 11 月 24 日

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

计划入组 12 人 · 首次发布于 2026 年 5 月 7 日

MSC - OneBiome UX Pilot Study

计划入组 90 人 · 首次发布于 2021 年 8 月 5 日

UX-HIE001

UX-EP001

UX- SP001

GB001, Inc.

United States

Unixell Biotech Receives FDA IND Clearance for First iPSC-Derived Allogeneic Cell Therapy for Focal Epilepsy

First Parkinson's Patient Shows Significant Motor Improvement with UX-DA001 Autologous Cell Therapy

CU Anschutz Clinical Research Recruitment Program Doubles Study Inquiries Through Website Redesign